Retina-Vitreous									
									
										2021 , Vol 30 , Num 3									
								
								
											        			Effectiveness of Aflibercept in a Case of TASS-Associated Macular Edema											        			
											        			
											        			
											        					MD, FEBO, Professor, Baskent University Medical Faculty, Ophthalmology Department, Adana Teaching and Medical Research Center, Adana,Turkey											        			
											        															        				
													        			DOI :
													        				10.37845/ret.vit.2021.30.54													        			
												        		
											        			
											        				Toxic anterior segment syndrome (TASS) is an acute, non-infectious postoperative inflammatory reaction of the anterior segment of the
eye, that usually develops 12-48 hours after intraocular surgery. Mostly, the inflammation is resolved with appropriate treatment within days
or weeks, with a good outcome; however, infrequently complications such as permanent corneal edema, secondary glaucoma, and chronic
macular edema can occur jeopardizing the visual outcome. The aim of this study is to present the clinical outcomes of intravitreal aflibercept
injection in a case with macular edema associated with TASS.											        			
											        			
											        			Keywords :
											        				Macular edema, Toxic anterior segment syndrome											        			
											        	 
						
 
	

